Logo for Gossamer Bio Inc

Gossamer Bio Investor Relations Material

Latest events

Logo for Gossamer Bio Inc

Collaboration with Chiesi Farmaceutici S.p.A. 2024

Gossamer Bio
Logo for Gossamer Bio

Q3 2024

7 Nov, 2024
Logo for Gossamer Bio

Corporate Presentation 2024

14 Aug, 2024
Access the full event backlog
Slides, Transcripts, and Reports from 11,000+ public companies

Latest reports from Gossamer Bio Inc

Access all reports
Gossamer Bio, Inc. is a U.S.-based biopharmaceutical company focused on the discovery, development, and commercialization of innovative therapeutics in immunology, inflammation, and oncology. The company’s research pipeline targets diseases with unmet medical needs, including autoimmune disorders, inflammatory conditions, and cancer. Gossamer Bio leverages its scientific expertise to advance novel drug candidates through clinical trials, aiming to deliver effective treatment options for complex and chronic illnesses. The company is headquartered in San Diego, California, and its shares are listed on the NASDAQ.